Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug;62(8):10935-10953.
doi: 10.1007/s12035-025-04929-y. Epub 2025 Apr 17.

Transcriptomics of Various Diseases Reveals the Core Role of Immune System Pathways in Retinal Damage Repair and Nerve Regeneration

Affiliations

Transcriptomics of Various Diseases Reveals the Core Role of Immune System Pathways in Retinal Damage Repair and Nerve Regeneration

Yuxiang Zhang et al. Mol Neurobiol. 2025 Aug.

Abstract

Retinal ganglion cells (RGCs) are the only neuronal bridges connecting retinal inputs to the brain's visual processing centers, enabling visual perception. The axon of RGCs forms the optic nerve, which transmits visual information to the visual cortex. Damage to RGCs and their axons results in irreversible visual impairment. Acute retinal damage is commonly induced by conditions such as optic nerve compression, glaucoma, and optic neuritis, for which effective clinical treatments are currently unavailable. Therefore, understanding the response of RGCs and their axons to injury is crucial for the development of potential treatments. This study utilizes multiple models including optic nerve crush (ONC), acute intraocular pressure (IOP) elevation, and local lipopolysaccharide (LPS) injection into the optic nerve to mimic eye diseases. Three days post-surgery, mice underwent retinal isolation followed by bulk-RNA sequencing to analyze differential gene expression among models. Using thresholds of |Log2 fold change (FC)|> 2 and p-value < 0.05, the significant gene expression changes observed in each model were as follows: ONC (upregulated, 456; downregulated, 84), IOP (upregulated, 1946; downregulated, 655), and LPS (upregulated, 219; downregulated, 94). Gene ontology (GO) analysis of the upregulated genes unexpectedly revealed that immune system pathways were the primary shared targets across all three models. In contrast, the downregulated genes exhibited model-specific enrichment: synaptic components and functions in IOP, neurogenesis and neuronal development in ONC, and inflammation and antioxidant in LPS. These findings were further confirmed by Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis. This suggests that managing immune activation is essential for treating acute retinal injury, and therapeutic strategies should address model-specific targets as well. Notably, 39 genes intersected across the models, and the protein-protein interaction (PPI) network identified Ccl5 as a key hub gene, underscoring its critical role in the pathophysiology of all three diseases.

Keywords: Glaucoma; Immune; Mice; Optic nerve; Optic nerve crush; Optic neuritis; Retina.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests.

Similar articles

References

    1. Laha B, Stafford BK, Huberman AD (2017) Regenerating optic pathways from the eye to the brain. Science 356(6342):1031–1034 - PubMed - PMC
    1. Jacobi A, Tran NM, Yan W et al (2022) Overlapping transcriptional programs promote survival and axonal regeneration of injured retinal ganglion cells. Neuron 110(16):2625-2645.e7 - PubMed - PMC
    1. Wang X, Yang C, Wang X et al (2023) Driving axon regeneration by orchestrating neuronal and non-neuronal innate immune responses via the IFNγ-cGAS-STING axis. Neuron 111(2):236-255.e7 - PubMed
    1. Ruan Y, Cheng J, Dai J et al (2023) Chronic stress hinders sensory axon regeneration via impairing mitochondrial cristae and OXPHOS. Sci Adv 9(40):eadh0183
    1. Fischer D, Leibinger M (2012) Promoting optic nerve regeneration. Prog Retin Eye Res 31(6):688–701 - PubMed

Substances

LinkOut - more resources